Prioritizing CD4 Count Monitoring in Response to ART in Resource-Constrained Settings: A Retrospective Application of Prediction-Based Classification

English version České info

Background:
Global programs of anti-HIV treatment depend on sustained laboratory capacity to assess treatment initiation thresholds and treatment response over time. Currently, there is no valid alternative to CD4 count testing for monitoring immunologic responses to treatment, but laboratory cost and capacity limit access to CD4 testing in resource-constrained settings. Thus, methods to prioritize patients for CD4 count testing could improve treatment monitoring by optimizing resource allocation.

Methods and Findings:
Using a prospective cohort of HIV-infected patients (n = 1,956) monitored upon antiretroviral therapy initiation in seven clinical sites with distinct geographical and socio-economic settings, we retrospectively apply a novel prediction-based classification (PBC) modeling method. The model uses repeatedly measured biomarkers (white blood cell count and lymphocyte percent) to predict CD4⁺ T cell outcome through first-stage modeling and subsequent classification based on clinically relevant thresholds (CD4⁺ T cell count of 200 or 350 cells/µl). The algorithm correctly classified 90% (cross-validation estimate = 91.5%, standard deviation [SD] = 4.5%) of CD4 count measurements <200 cells/µl in the first year of follow-up; if laboratory testing is applied only to patients predicted to be below the 200-cells/µl threshold, we estimate a potential savings of 54.3% (SD = 4.2%) in CD4 testing capacity. A capacity savings of 34% (SD = 3.9%) is predicted using a CD4 threshold of 350 cells/µl. Similar results were obtained over the 3 y of follow-up available (n = 619). Limitations include a need for future economic healthcare outcome analysis, a need for assessment of extensibility beyond the 3-y observation time, and the need to assign a false positive threshold.

Conclusions:
Our results support the use of PBC modeling as a triage point at the laboratory, lessening the need for laboratory-based CD4⁺ T cell count testing; implementation of this tool could help optimize the use of laboratory resources, directing CD4 testing towards higher-risk patients. However, further prospective studies and economic analyses are needed to demonstrate that the PBC model can be effectively applied in clinical settings.

: Please see later in the article for the Editors' Summary

Vyšlo v časopise: Prioritizing CD4 Count Monitoring in Response to ART in Resource-Constrained Settings: A Retrospective Application of Prediction-Based Classification. PLoS Med 9(4): e32767. doi:10.1371/journal.pmed.1001207
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1001207

Souhrn

Zdroje

1. World Health Organization 2010 Antiretroviral therapy for HIV infection in adults and adolescents. recommendations for a public health approach Geneva World Health Organization

2. Delta Coordinating Committee and Virology Group 1999 An evaluation of HIV RNA and CD4 cell count as surrogates for clinical outcome. Delta Coordinating Committee and Virology Group. AIDS 13 565 573

3. LimaVDFinkVYipBHoggRSHarriganPR 2009 Association between HIV-1 RNA level and CD4 cell count among untreated HIV-infected individuals. Am J Public Health 99 Suppl 1 S193 S196

4. BadriMLawnSDWoodR 2008 Utility of CD4 cell counts for early prediction of virological failure during antiretroviral therapy in a resource-limited setting. BMC Infect Dis 8 89

5. ManghamLJHansonK 2010 Scaling up in international health: what are the key issues? Health Policy Plan 25 85 96

6. ClearySM 2010 Commentary: trade-offs in scaling up HIV treatment in South Africa. Health Policy Plan 25 99 101

7. ClearySMMcIntyreDBoulleAM 2008 Assessing efficiency and costs of scaling up HIV treatment. AIDS 22 Suppl 1 S35 S42

8. Van DammeWKoberKKegelsG 2008 Scaling-up antiretroviral treatment in Southern African countries with human resource shortage: how will health systems adapt? Soc Sci Med 66 2108 2121

9. CohenGM 2007 Access to diagnostics in support of HIV/AIDS and tuberculosis treatment in developing countries. AIDS 21 Suppl 4 S81 S87

10. BarnighausenTBloomDEHumairS 2007 Human resources for treating HIV/AIDS: needs, capacities, and gaps. AIDS Patient Care STDS 21 799 812

11. AbimikuAG 2009 Building laboratory infrastructure to support scale-up of HIV/AIDS treatment, care, and prevention: in-country experience. Am J Clin Pathol 131 875 886

12. ChenRYWestfallAOHardinJMMiller-HardwickCStringerJS 2007 Complete blood cell count as a surrogate CD4 cell marker for HIV monitoring in resource-limited settings. J Acquir Immune Defic Syndr 44 525 530

13. CalmyAFordNHirschelBReynoldsSJLynenL 2007 HIV viral load monitoring in resource-limited regions: optional or necessary? Clin Infect Dis 44 128 134

14. SchooleyRT 2007 Viral load testing in resource-limited settings. Clin Infect Dis 44 139 140

15. BagchiSKempfMCWestfallAOMaheryaAWilligJ 2007 Can routine clinical markers be used longitudinally to monitor antiretroviral therapy success in resource-limited settings? Clin Infect Dis 44 135 138

16. MiiroGNakubulwaSWateraCMunderiPFloydS 2010 Evaluation of affordable screening markers to detect CD4+ T-cell counts below 200 cells/mul among HIV-1-infected Ugandan adults. Trop Med Int Health 15 396 404

17. GuptaAGupteNBhosaleRKakraniAKulkarniV 2007 Low sensitivity of total lymphocyte count as a surrogate marker to identify antepartum and postpartum Indian women who require antiretroviral therapy. J Acquir Immune Defic Syndr 46 338 342

18. MarshallSSippyNBroomeHAbayomiA 2006 Quality control of the total lymphocyte count parameter obtained from routine haematology analyzers, and its relevance in HIV management. Afr J Med Med Sci 35 161 163

19. GituraBJoshiMDLuleGNAnzalaO 2007 Total lymphocyte count as a surrogate marker for CD4+ t cell count in initiating antiretroviral therapy at Kenyatta National Hospital, Nairobi. East Afr Med J 84 466 472

20. FoulkesASAzzoniLXiaohongLJohnsonMASmithC 2010 Prediction based classification for longitudinal biomarkers. Ann Appl Stat 4 1476 1497

21. PattanapanyasatKPhuang-NgernYSukapiromKLerdwanaSThepthaiC 2008 Comparison of 5 flow cytometric immunophenotyping systems for absolute CD4+ T-lymphocyte counts in HIV-1-infected patients living in resource-limited settings. J Acquir Immune Defic Syndr 49 339 347

22. PeterTBadrichaniAWuEFreemanRNcubeB 2008 Challenges in implementing CD4 testing in resource-limited settings. Cytometry B Clin Cytom 74 Suppl 1 S123 S130

23. PeterTFRotzPDBlairDHKhineAAFreemanRR 2010 Impact of laboratory accreditation on patient care and the health system. Am J Clin Pathol 134 550 555

24. MarinucciFMedina-MorenoSPaternitiADWattleworthMRedfieldRR 2011 Decentralization of CD4 testing in resource-limited settings: 7 years of experience in six African countries. Cytometry A 79 368 374

25. KumarasamyNMahajanAPFlaniganTPHemalathaRMayerKH 2002 Total lymphocyte count (TLC) is a useful tool for the timing of opportunistic infection prophylaxis in India and other resource-constrained countries. J Acquir Immune Defic Syndr 31 378 383

26. MahajanAPHoganJWSnyderBKumarasamyNMehtaK 2004 Changes in total lymphocyte count as a surrogate for changes in CD4 count following initiation of HAART: implications for monitoring in resource-limited settings. J Acquir Immune Defic Syndr 36 567 575

27. ZachariahRReidSDChailletPMassaquoiMSchoutenEJ 2011 Viewpoint: why do we need a point-of-care CD4 test for low-income countries? Trop Med Int Health 16 37 41